Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

4.05
Delayed Data
As of Aug 28
 +0.37 / +10.05%
Today’s Change
3.44
Today|||52-Week Range
11.74
-42.14%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close3.68
Today’s open3.64
Day’s range3.64 - 4.15
Volume112,616
Average volume (3 months)172,989
Market cap$72.6M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)-11.90%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp+0.12+3.93%
APDNApplied DNA Sciences...+0.09+2.67%
BOTABiota Pharmaceutical...0.000.00%
IMMYImprimis Pharmaceuti...0.000.00%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

Partner Offers